Combined modality treatment in the management of high-risk prostate cancer

The efficacy of a multimodality protocol using neoadjuvant and concomitant hormonal therapy, brachytherapy, and three-dimensional conformal external beam radiotherapy (RT) in high-risk prostate cancer was evaluated using biochemical outcomes and posttreatment biopsy results. Between February 1994 an...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of radiation oncology, biology, physics Vol. 59; no. 5; p. 1352
Main Authors:	Stock, Richard G, Cahlon, Oren, Cesaretti, Jamie A, Kollmeier, Marisa A, Stone, Nelson N
Format:	Journal Article
Language:	English
Published:	United States 01.08.2004
Subjects:	Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Brachytherapy Combined Modality Therapy Finasteride - therapeutic use Flutamide - therapeutic use Gonadotropin-Releasing Hormone - agonists Humans Male Palladium - therapeutic use Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - radiotherapy Radioisotopes - therapeutic use Radiotherapy, Conformal Testosterone - blood
ISSN:	0360-3016
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!